Articles from Levi & Korsinsky, LLP

Wall Street Reassessment: Analysts pressed O-I Glass for more than a year on Europe and its unchanged 2027 EBITDA target. The lawsuit alleges management's answers omitted delayed Fit to Win savings and mounting energy costs.

Important Information Regarding Section 20(a) Individual Liability Claims: the lawsuit charges that CEO Tianhua Wu and CFO John Fei Zeng certified three annual reports describing CSRC rectification while UP Fintech subsidiaries allegedly kept running unlicensed securities business in mainland China

Important Information Regarding Section 20(a) Individual Liability Claims: Tenax's chief executive and three successive chief financial officers face control person claims over allegedly misleading statements about TNX-103

From Optimism to Disillusionment: a securities lawsuit alleges D-Wave overstated its growth and operational momentum, and investor confidence in QBTS eroded once reported revenue failed to keep pace with the story

Gildan's SEC filings cautioned that internal controls "may not prevent or detect misstatements." The lawsuit alleges that generic warning left investors unaware of channel stuffing that pulled roughly $500 million in revenue forward

Time-Sensitive: Allegations Focus on Lennar Related-Party Representations. The lawsuit alleges that Millrose purchased homes from its former parent, Lennar, through non-arm’s-length agreements that helped Lennar clear a quarterly delivery target

Wall Street Reassessment: Analyst Opinion Evolution on CC. UBS, Morgan Stanley, and J.P. Morgan cut Chemours price targets by as much as 37.9% after a 2026 guidance cut that the lawsuit alleges followed months of overstated Opteon aftermarket demand.

Pension funds, asset managers, and ERISA fiduciaries that received Compass stock in the $4.2 billion Anywhere merger exchange may wish to review claims that the Offering Materials omitted an alleged political backchannel to the DOJ.

Key Dates and Disclosure Events Shareholders Need to Know. The Webull timeline of disclosure events, as alleged, traces China-independence assurances repeated across three SEC filings to a single-session 19% share decline on October 7, 2026.

Promise vs. Reality: The Duolingo Performance Gap. Duolingo called 49% user growth proof of "meaningful growth at scale," but the lawsuit contends that friction-heavy monetization and mass-produced AI lessons were already steering that figure toward a 20% forecast

Important information regarding Section 20(a) individual liability claims: the lawsuit alleges Beta Bionics' CEO and CFO certified SEC filings while a June 2025 FDA Form 483 citing more than 18,000 unreported iLet complaints was allegedly withheld from shareholders

Wall Street pressed Papa John's management on its reacceleration promises as early as August 2025. The securities action alleges the answers analysts received were materially misleading, and PZZA shareholders absorbed a $5.11 per-share loss when the 2026 outlook was slashed

A securities class action alleges Unicycive Therapeutics resubmitted its oxylanthanum carbonate New Drug Application without ever inspecting its third-party manufacturer's facility for cGMP compliance. Pension funds, asset managers, and other fiduciaries that held UNCY during the Class Period may wish to evaluate lead plaintiff options.

Wall Street cut price targets and said its "conviction materially" declined after DICK'S Sporting Goods disclosed that Foot Locker's legacy footwear exposure was pressuring sales and margins, months after management allegedly assured the market that the inventory cleanup was finished

A securities class action alleges Ryde Group Ltd's audited financial statements and offering documents omitted the market manipulation risk built into its low-float NYSE listing, allegedly leaving Class Period purchasers vulnerable to a sharp price collapse

Important Notice Regarding Alleged Manufacturing Capacity Misrepresentations: a securities class action contends FuelCell Energy did not disclose that its plant capacity was inadequate to produce at the rate its Fit Energy contract required, resulting in a $17.0 million charge

A securities class action alleges Lincoln Educational Services reported 9% enrollment growth in the second quarter of 2026, while student starts increased by only about 1%. This notice sets out the rights available to LINC purchasers who bought between May 11, 2026 and August 9, 2026.

Disclosure under scrutiny: AST SpaceMobile's SEC filings repeatedly stated that cash on hand would be "sufficient" for the next 12 months, yet the Company allegedly went on to announce $3.0 billion of convertible notes across three offerings in nine months

A securities class action alleges Baidu, Inc. spent three consecutive quarters telling investors its AI-powered business was cushioning a collapsing legacy search advertising franchise, until the AI business itself contracted 8% sequentially and BIDU shares lost $13.25 in a single session.

Doximity co-founder and former Chief Strategy Officer Nate Gross is named as a defendant in a securities class action alleging the Company assured investors it could "gain share" while older advertising formats were allegedly losing ground to programmatic and social competitors.

A securities class action traces AppLovin's alleged disclosure failures across a six-month chronology, from February 2026 assurances that AI model gains would not slow to the August 5, 2026 concession that the pace of model improvement was "lighter than normal."

Promise vs. Reality: Ardelyx pointed investors toward $1.75 billion in combined peak sales for IBSRELA and XPHOZAH, while the complaint alleges payer utilization-management barriers were already restricting patient access before the Company cut 2026 guidance and withdrew its long-term XPHOZAH target.

Notice to pension funds, asset managers, and other fiduciaries: a securities class action alleges Better Home & Finance failed to disclose that its loan conversion funnel was already slowing, leaving BETR holders to absorb a $12.17 per-share single-session decline.

Promise vs. reality: weeks after guiding investors to 7% to 9% organic growth, Honeywell Aerospace reported a 70% drop in quarterly net income and cut its outlook.

Key Dates and Disclosure Events Shareholders Need to Know: The complaint traces a five-month path from Qfin's upbeat assurances about PRC regulation to a 76.8% profit collapse and a one-day 18.91% ADS decline.

Important Notice Regarding Alleged Contract Manufacturing Readiness Misrepresentations: Fluence Energy's fiscal 2026 revenue outlook allegedly depended on new production facilities that were not completed, not operational, or not capable of the volumes the guidance assumed.

The securities action asserts that Coastal Financial's public assurances of "strong regulatory stewardship" and disciplined CCBX credit oversight violated Section 10(b) and Rule 10b-5. Those assurances preceded a $68.8 million single-partner charge that sent CCB shares down 43.5%.

Alphabet shareholder rights in focus: the securities action alleges a promised June 2026 Gemini 3.5 Pro launch masked disappointing training results. Class Period purchasers of GOOGL and GOOG may pursue claims whether or not they still hold their shares.

Diebold Nixdorf lowered its 2026 adjusted earnings outlook by up to $0.90 per share on October 28, 2026, a cut of as much as 15.7% to the per-share figure DBD shareholders had been given. Levi & Korsinsky is investigating potential securities law violations on behalf of investors who lost money.

Xylem's new 2026 adjusted EPS ceiling of $5.45 now sits below the $5.55 floor it replaced. An investigation into potential securities law violations is reviewing losses suffered by XYL shareholders

Promise vs. Reality: The D-Wave Performance Gap. A securities fraud lawsuit alleges D-Wave overstated its prospects while calling 2026 a "defining year," then reported second quarter revenue below the prior-year level

A securities class action alleges Unicycive Therapeutics told investors its third-party manufacturer had made "significant progress" toward regaining FDA compliance, while the Company had never verified that claim through its own inspection of the facility

A securities class action traces Ryde Group Ltd from its $4.00 March 2024 IPO to the September 11, 2024 session which saw the stock price collapse, allegedly after months of coordinated social media promotion

Six incoming directors named in York Space Systems' January 2026 registration statement, including (Ret.) Gen. James McConville, and an eleven-bank underwriting syndicate led by Goldman Sachs are named as defendants in a securities action alleging the $34.00 IPO documents omitted that onboard mission and payload software was not fully functional before satellites launched

A securities class action alleges Lincoln Educational Services told the market its investment in "people and processes" was lifting student retention, while allegedly omitting observed shifts in student decision-making and loan defaults that were choking conversion from enrollment to attendance

Market Reaction Focus: PZZA shares repriced by $5.11 in a single session, a 17.18% decline, after Papa John's reported an 8.3% drop in North American comparable sales, suspended its dividend, and cut its 2026 outlook. The action alleges those disclosures contradicted earlier assurances that the Company's transformation was working

Disclosure under scrutiny: a securities class action alleges Honeywell Aerospace's SEC filings warned only that False Claims Act enforcement "could" happen while a Justice Department cybersecurity inquiry was allegedly already pending, and HONA shareholders lost $49.40 per share across two purported corrective events

A securities class action alleges Hyliion promoted a $133 million non-binding letter of intent with a four-employee counterparty as a "new data center partnership" — and HYLN purchasers who lost $2.45 per share retain rights whether or not they still hold the stock

Notice to pension funds, asset managers, and fiduciaries: a securities class action alleges Innventure's flagship 300MW AI data center agreement rested on a counterparty later described in a research report as a shell company, ahead of a 55% single-day collapse in INV shares.

Promise vs. Reality: The Alphabet Gemini 3.5 Pro Gap. A securities fraud lawsuit alleges Alphabet promised investors a June 2026 launch of its flagship AI model while disappointing training results went undisclosed, a promise-reality gap that ended when the model was abruptly delayed

Key Dates and Disclosure Events Shareholders Need to Know: Compass's merger timeline pointed to a second-half 2026 close, but the lawsuit alleges an undisclosed DOJ backchannel, not ordinary regulatory review, produced a January 9, 2026 close.

The complaint charges that Coastal's CEO and two successive CFOs controlled the Company's CCBX credit-quality assurances, and that two of those officers sold roughly $15.8 million in stock before a 43.5% single-day decline.

Notice to Pension Funds, Asset Managers, and Fiduciaries: The lawsuit alleges Millrose Properties told the market it would have no tenants, then bought an estimated $200 million of finished Lennar homes to rent, leaving institutional holders to weigh their fiduciary recovery options

Important Notice Regarding Alleged Opteon Aftermarket Demand Misrepresentations. The lawsuit claims that record 2025 refrigerant sales reflected an overfilled distribution channel, which set up a 2026 sales decline for Chemours shareholders.

The lawsuit alleges Gildan presented its controls as effective under both U.S. Exchange Act rules and Canada's National Instrument 52-109 while channel stuffing allegedly pulled roughly $500 million in revenue forward

Notice to pension funds, asset managers, and other fiduciaries: a securities class action alleges Baidu, Inc. (NASDAQ: BIDU) overstated the ability of its AI-powered business to cushion a rapidly deteriorating legacy online marketing franchise.

A securities class action alleges DICK'S Sporting Goods slashed its Foot Locker comparable sales outlook from growth of 1.5% to 3% down to negative 2.0% to 0.0%, and DKS purchasers may have rights to recovery they have not yet reviewed.

Important Information Regarding Section 20(a) Individual Liability Claims: Qfin's Class Period CEO and its CFO, who signed Sarbanes-Oxley certifications on the Company's 2025 annual report, face alleged personal liability as control persons for a $2.18-per-ADS investor loss

A securities class action alleges Better Home & Finance reaffirmed a $1.0 billion monthly funded volume target while customer conversion rates were already slipping, and BETR shares repriced 28.5% lower in a single session on May 7, 2026.

Fluence Energy's annual and quarterly SEC reports allegedly assured investors of adequate supply access and unchanged risks while the new contract manufacturing capacity behind its fiscal 2026 guidance was not ready, the Exchange Act complaint contends

A securities class action alleges FuelCell Energy's manufacturing operation could not meet its Fit Energy Phase 0 commitment, leaving per-unit costs above contracted pricing and triggering a $17.0 million charge

A securities class action alleges Beta Bionics assured shareholders that an FDA Form 483 was a "very benign" reporting technicality, and investor confidence held for months until the agency's Warning Letter became public and BBNX shares declined.

The Red Flags: What Insiders Allegedly Knew Before Shareholders Did. Webull purchasers have rights under federal securities law to pursue recovery after a congressional inquiry reportedly found the broker's China ties ran far deeper than its filings allegedly disclosed.

Were the risk warnings adequate? The complaint challenges AST SpaceMobile's previous statements, alleging it omitted the risks of slow user adoption in the U.S. and Japan and the dilution that followed three separate $1.0 billion convertible note offerings.

EyePoint Pharmaceuticals shareholders lost nearly 67% of their share value in a single session after the Phase 3 LUCIA topline readout. Levi & Korsinsky is investigating potential securities law violations on behalf of EYPT shareholders who lost money

Ardelyx's chief executive, two successive chief financial officers, and its chief commercial officer are each named as individual defendants in a securities class action alleging they controlled public statements projecting $1.75 billion in combined peak sales for XPHOZAH and IBSRELA while payer access barriers were allegedly building.

Promise versus reality: Doximity told investors its Newsfeed was driving record engagement and growth, yet the securities action alleges the Company was losing share to competitors, lowered its fiscal 2026 revenue guidance, and then missed even that reduced target, sending DOCS to a close of $18.01

In May 2026, AppLovin management told investors it had "100% seen faster improvements" to its AI models and saw no reason for that pace to "slow down," while promising its generative AI video tool would reach all accounts "shortly." Twelve weeks later the Company reported model improvement had been "lighter than normal" and the video tool was "still [a] work in progress."

DURAVYU’s Phase 3 LUCIA trial missed its primary endpoint and EYPT shares lost nearly 80% of their value in a single session. Levi & Korsinsky is investigating on behalf of shareholders who may have legal rights arising from those losses

Fox Factory’s preliminary third-quarter fiscal 2026 net sales were $336 million to $340 million, reflecting weaker-than-expected performance. The investigation concerns potential securities law violations

A third-quarter revenue outlook of $65 million to $125 million, against a Street consensus of roughly $868 million, sent FMC shares down as much as 46%. An investigation concerns potential securities law violations connected to the Company's securities offering disclosures

Promise vs. reality: FuelCell Energy announced an agreement for up to 380 MW of fuel cell power and told investors the deal validated scaling to 500 MW, yet a securities class action alleges the Company failed to appropriately caution investors of the possibility it would be unable to achieve contractual targets under the agreement and would have to incur charges thereunder. When the shortfall became a reality and the $17 million charge was announced, the stock fell 15.69% in a single-day.

Forensic research publicly warned on September 9, 2024 that Ryde Group Ltd carried "all the hallmarks" of a pump-and-dump; two days later a securities class action alleges RYDE purchasers watched the stock price sink

A securities class action alleges Unicycive Therapeutics leaned on a contract manufacturer already cited by the FDA for cGMP deficiencies, without verifying the vendor's compliance status, before the same deficiencies triggered a second Complete Response Letter and a 39.1% single-day collapse in UNCY shares.

Important information regarding Section 20(a) individual liability claims: the action alleges AST SpaceMobile's CEO and CFO personally certified filings that overstated the sufficiency of the Company's capital position while, as the complaint identifies, selling more than $18 million of their own stock during the Class Period

A securities class action alleges DICK'S Sporting Goods characterized athletic footwear promotional pressure as nothing management was "particularly concerned about," while allegedly omitting Foot Locker's dependence on the products exposed to such pressures.

Promise versus reality: the lawsuit contends Beta Bionics promoted "superior clinical outcomes" for its iLet insulin pump while a June 2025 FDA Form 483 documenting more than 18,000 unreported customer complaints stayed out of public view, and BBNX shares later fell roughly $23.09 from their Class Period high.

Key dates and disclosure events shareholders need to know: the securities action traces a chronology running from the Company's August 7, 2025 assurances about its strategic transformation to the August 6, 2026 guidance reset and dividend suspension that preceded a 17.18% single-session decline in PZZA shares

Important Information Regarding Section 20(a) Individual Liability Claims: The lawsuit names Millrose's CEO and CFO, who allegedly signed SEC filings pledging no tenants before the Company bought an estimated $200 million of Lennar homes to rent out.

Investors who acquired York Space Systems stock in or traceable to the Company's January 2026 IPO at $34.00 per share are urged to review their options. The action contends the registration statement touted "proven" and "scalable" satellite technology while omitting that onboard mission and payload software was allegedly not fully functional before launch.

Alert: Claims Focus on Alleged Misrepresentations About TSS Channel Inventory. The lawsuit centers on roughly $65 million in Opteon refrigerant aftermarket sales that distributor stocking allegedly shifted out of 2026 and into 2025.

Hyliion described roughly $400 million in potential pipeline revenue "at today's current pricing," but the securities class action alleges its disclosures never told investors what diligence, if any, supported the $133 million VFG letter of intent behind about one-third of that figure.

Time-Sensitive: Allegations focus on Ardelyx's representations that its patient-access strategy was working, while more stringent prior authorization and step edit requirements were allegedly slowing new-patient starts for IBSRELA and XPHOZAH.

Alert: Claims focus on alleged misrepresentations about the commercialization of Accelsius' NeuCool liquid cooling systems, including a 300MW deployment Innventure later removed from its internal bookings.

Important Information Regarding Individual Liability Claims: Compass's CEO and CFO signed merger Offering Materials that allegedly promised "reasonable best efforts" through ordinary regulatory channels while a Trump-aligned lawyer was allegedly retained to bypass DOJ antitrust review